Telomerase-specific oncolytic adenovirus: Antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Telomerase-specific oncolytic adenovirus: Antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells
Authors
Keywords
-
Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 36, Issue 3, Pages 411-418
Publisher
Wiley
Online
2013-06-01
DOI
10.1002/hed.23309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment
- (2012) Yuuri Hashimoto et al. PLoS One
- Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines
- (2011) Atsuko Sakakibara et al. AURIS NASUS LARYNX
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Disruptive TP53 Mutation Is Associated with Aggressive Disease Characteristics in an Orthotopic Murine Model of Oral Tongue Cancer
- (2011) D. Sano et al. CLINICAL CANCER RESEARCH
- TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence
- (2011) H. D. Skinner et al. CLINICAL CANCER RESEARCH
- Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro
- (2011) D. Sano et al. CLINICAL CANCER RESEARCH
- Telomerase-Dependent Oncolytic Adenovirus Sensitizes Human Cancer Cells to Ionizing Radiation via Inhibition of DNA Repair Machinery
- (2010) S. Kuroda et al. CANCER RESEARCH
- Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma
- (2010) Kondo ONCOLOGY REPORTS
- Advances in radiotherapy for head and neck cancer
- (2010) S.A. Bhide et al. ORAL ONCOLOGY
- Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination
- (2009) M Takakura et al. CANCER GENE THERAPY
- Radiation enhances suicide gene therapy in radioresistant laryngeal squamous cell carcinoma via activation of a tumor-specific promoter
- (2009) Zhengkai Liao et al. CANCER LETTERS
- Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer
- (2009) D. Liu et al. MOLECULAR CANCER THERAPEUTICS
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- How Telomeres Solve the End-Protection Problem
- (2009) T. de Lange SCIENCE
- Xenograft models of head and neck cancers
- (2009) Daisuke Sano et al. Head and Neck Optical Diagnostics Society
- Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus
- (2008) Yuuri Hashimoto et al. CANCER SCIENCE
- Telomere dysfunction is related to the intrinsic radio-resistance of human oral cancer cells
- (2007) James A. McCaul et al. ORAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started